Halpern Vera, Lopez Laureen M, Grimes David A, Stockton Laurie L, Gallo Maria F
Clinical Sciences, FHI 360, PO Box 13950, Research Triangle Park, North Carolina, USA, NC 27709.
Cochrane Database Syst Rev. 2013 Oct 26(10):CD004317. doi: 10.1002/14651858.CD004317.pub4.
Worldwide, hormonal contraceptives are among the most popular reversible contraceptives. Despite their high theoretical effectiveness, typical use results in much lower effectiveness. In large part, this disparity reflects difficulties in adherence to the contraceptive regimen and low rates for long-term continuation.
The intent was to determine the effectiveness of ancillary counseling techniques to improve adherence to, and continuation of, hormonal methods of contraception.
Through August 2013, we searched computerized databases for randomized controlled trials (RCTs) comparing client-provider interventions with standard family planning counseling. Sources included CENTRAL, MEDLINE, EMBASE, POPLINE, ClinicalTrials.gov and ICTRP. Earlier searches also included LILACS, PsycINFO, Dissertation Abstracts, African Index Medicus, and IMEMR.
We included RCTs of an intensive counseling technique or other client-provider intervention compared to routine family planning counseling. Interventions included group motivation; structured, peer, or multi-component counseling; and intensive reminders of appointments or next dosing. Outcome measures were discontinuation, reasons for discontinuation, number of missed pills or on-time injections, and pregnancy.
One author evaluated the titles and abstracts from the searches to determine eligibility. Two authors extracted data from the included studies. We calculated the Mantel-Haenszel odds ratio (OR) for dichotomous outcomes. For continuous variables, the mean difference (MD) was computed; RevMan uses the inverse variance approach. For all analyses, 95% confidence intervals (CI) were also computed. Since the studies identified differed in both interventions and outcome measures, we did not conduct a meta-analysis.
Nine RCTs met our inclusion criteria. Five involved direct counseling; of those, two also provided multiple contacts by telephone. Four other trials provided intensive reminders, two of which also provided health education information. Three trials showed some benefit of the experimental intervention. In a counseling intervention, women who received repeated structured information about the injectable depot medroxyprogesterone acetate (DMPA) were less likely to discontinue the method by 12 months (OR 0.27; 95% CI 0.16 to 0.44) than women who had routine counseling. The intervention group was also less likely to discontinue due to menstrual disturbances (OR 0.20; 95% CI 0.11 to 0.37). Another trial showed a group with special counseling plus phone calls was more likely than the special-counseling group to report consistent use of oral contraceptives (OC) at 3 months (OR 1.41; 95% CI 1.06 to 1.87), though not at 12 months. The group with only special counseling did not differ significantly from those with standard care for any outcome. The third trial compared daily text-message reminders about OCs plus health information versus standard care. Women in the text-message group were more likely than the standard-care group to continue OC use by six months (OR 1.54; 95% CI 1.14 to 2.10). The text-message group was also more likely to avoid an interruption in OC use longer than seven days (OR 1.53; 95% CI 1.13 to 2.07).
AUTHORS' CONCLUSIONS: Only three trials showed some benefit of strategies to improve adherence and continuation. However, several had small sample sizes and six had high losses to follow up. The overall quality of evidence was considered moderate. The intervention type and intensity varied greatly across the studies. A combination of intensive counseling and multiple contacts and reminders may be needed to improve adherence and acceptability of contraceptive use. High-quality RCTs with adequate power and well-designed interventions could help identify ways to improve adherence to, and continuation of, hormonal contraceptive methods.
在全球范围内,激素避孕药是最受欢迎的可逆性避孕方法之一。尽管其理论有效性较高,但实际使用效果却低得多。在很大程度上,这种差异反映了坚持避孕方案的困难以及长期持续使用的低比率。
旨在确定辅助咨询技术对提高激素避孕方法的依从性和持续使用的有效性。
截至2013年8月,我们在计算机化数据库中检索了比较客户 - 提供者干预与标准计划生育咨询的随机对照试验(RCT)。来源包括Cochrane系统评价数据库、医学索引数据库、荷兰医学文摘数据库、人口信息数据库、临床试验.gov和国际临床试验注册平台。早期检索还包括拉丁美洲和加勒比地区卫生科学数据库、心理学文摘数据库、论文摘要数据库、非洲医学索引和印度医学研究理事会数据库。
我们纳入了与常规计划生育咨询相比的强化咨询技术或其他客户 - 提供者干预的随机对照试验。干预措施包括群体激励;结构化、同伴或多成分咨询;以及强化预约提醒或下次服药提醒。结局指标为停药、停药原因、漏服避孕药或按时注射次数以及妊娠情况。
一位作者评估检索结果中的标题和摘要以确定是否符合纳入标准。两位作者从纳入研究中提取数据。我们计算了二分结局的Mantel - Haenszel优势比(OR)。对于连续变量,计算平均差(MD);RevMan使用逆方差法。对于所有分析,还计算了95%置信区间(CI)。由于所确定的研究在干预措施和结局指标方面均存在差异,因此我们未进行荟萃分析。
九项随机对照试验符合我们的纳入标准。五项涉及直接咨询;其中两项还通过电话提供多次联系。其他四项试验提供强化提醒,其中两项还提供健康教育信息。三项试验显示了实验性干预的一些益处。在一项咨询干预中,与接受常规咨询的女性相比,接受关于醋酸甲羟孕酮长效注射剂(DMPA)的重复结构化信息的女性在12个月时停用该方法的可能性较小(OR 0.27;95%CI 0.16至0.44)。干预组因月经紊乱而停药的可能性也较小(OR 0.20;95%CI 0.11至0.37)。另一项试验表明,接受特殊咨询加电话随访的组在3个月时比仅接受特殊咨询的组更有可能报告持续使用口服避孕药(OC)(OR 1.41;95%CI 1.06至1.87),但在12个月时并非如此。仅接受特殊咨询的组与接受标准护理的组在任何结局方面均无显著差异。第三项试验比较了关于口服避孕药的每日短信提醒加健康信息与标准护理。短信组的女性在6个月时比标准护理组更有可能继续使用口服避孕药(OR 1.54;95%CI 1.14至2.10)。短信组也更有可能避免口服避孕药使用中断超过7天(OR 1.53;95%CI 1.13至2.07)。
只有三项试验显示了改善依从性和持续使用的策略的一些益处。然而,其中几项样本量较小,六项随访损失率较高。证据的总体质量被认为是中等的。各项研究中的干预类型和强度差异很大。可能需要强化咨询与多次联系及提醒相结合,以提高避孕使用的依从性和可接受性。具有足够效力和精心设计干预措施的高质量随机对照试验有助于确定改善激素避孕方法的依从性和持续使用的方法。